SCH-53870 is used in cancer research as a Ras activation inhibitor by binding to the Ras-GDP complex, thereby maintaining Ras in its inactive GDP-bound state and preventing its transition to the active GTP-bound form; it modulates cell signaling and proliferation through inhibition of Ras activation.